GOOGL vs MRK: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Alphabet Inc. · Communication Services
$342.36
+16.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
GOOGL has more upside to fair value
(+16.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOGL |
MRK |
| Current Price |
$342.36 |
$147.17 |
| Fair Value Estimate |
$399.26 |
$141.07 |
| Upside to Fair Value |
+16.6%
|
-4.1%
|
| Market Cap |
$4,143.3B |
$363.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
12.9x
|
29.6x
|
| Price / Sales |
9.3x
|
5.5x
|
| Price / FCF |
78.1x
|
22.6x
|
| Revenue Growth YoY |
+24.2%
|
+5.1%
|
| Gross Margin |
60.9%
|
75.4%
|
| Operating Margin |
33.1%
|
16.7%
|
| Return on Equity |
50.8%
|
6.6%
|
| Dividend Yield |
0.25% |
2.31% |
| FCF Yield |
1.28%
|
4.42%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Alphabet is the parent of Google Services (Search, YouTube, Android, Chrome, hardware, and the Play store), Google Cloud, and Other Bets, and it remains one of the highest-quality large-cap franchises in the market, with a TTM gross margin of 60.9%, TTM operating margin of 33.1%, TTM net margin of 54.8%, and a 50.8% return on equity. Revenue growth in the most recent quarter was 24.2% year over y…
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
| Metric |
GOOGL |
MRK |
| Zone Low |
$299.44 |
$105.80 |
| Zone High |
$339.37 |
$119.91 |
| In Buy Zone? |
No
|
No
|